MetaCap

MacroGenics (MGNX) News

NASDAQ: MGNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.96-0.02 (-1.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MGNX news summary

We found 7 recent headlines mentioning MacroGenics (MGNX): 0 in the past week and 6 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, MGNX is down 1.01% at $1.96. The most recent story, "MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates", was published by Nasdaq on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest MacroGenics headlines

Stocks mentioned alongside MGNX

Compare MGNX